期刊文献+

药品未注册用药现状及在神经肿瘤化疗中的应用 被引量:2

Off-label Use of Anticancer Drugs in Neuro-oncology
下载PDF
导出
摘要 药品未注册用药是指药品使用的适应症、适应人群、给药方法或剂量不在药品说明书之内的用法。药品未注册用药现象普遍存在于抗肿瘤治疗中,并成为一个越来越突出的有争议的问题。本文介绍国内外药品未注册用药的现状及存在问题,并探讨神经肿瘤化疗领域药品未注册用药的意义和注意事项,以及非注册临床研究的重要性。 Off-label drug use includes the uses of a drug product in indications,patient populations,routes of administration or doses that are not reflected health administration-approved product labeling.Off-label use of drugs to treat cancer is particularly common,and is becoming a subject with much debate.This article introduced the current status and debate about off-label drug use,indicating the significance in chemotherapy of nervous system neoplasms and the importance of non-registration clinical studies.
出处 《中国神经肿瘤杂志》 2012年第1期1-5,共5页 Chinese Journal of Neuro-Oncology
关键词 神经系统肿瘤 化学疗法 药品未注册用法 Nervous system neoplasms Chemotherapy Off-label drug use
  • 相关文献

参考文献19

二级参考文献58

共引文献164

同被引文献37

  • 1谢沐风.改善溶出度评价方法,提高固体药物制剂水平[J].中国医药工业杂志,2005,36(7):447-451. 被引量:124
  • 2邵蓉,蒋正华,黄泰康.医疗机构涉药人员执业风险防范与规避[J].中国药房,2007,18(28):2163-2164. 被引量:25
  • 3广东省药学会.关于印发《药品未注册用法专家共识》的通知[J].(http://zwgk.gd.gov.cn/00694124X/201107/t20110701_191813.html).
  • 4Ferraz MB, Tugwell P, Goldsmith CH, et al.Meta-analysis of sulfasalazine in ankylosing spondylitis[J].J Rheumatol, 1990, 17(11):1482-1486.
  • 5Chen J, Liu C. Sulfasalazine for ankylosing spondylitis [J]. Cochrane Database Syst Rev , 2005, (2): CD004800.
  • 6Braun J, Haibel H, Hammer M, et al. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis:a multicentre randomised controlled trial[J].Ann Rheum Dis, 2006.65(9): 1147-1153.
  • 7Weinblatt ME, Reda D, Henderson W, et al.Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials[J]. J Rheumatol, 1999, 26(10):2123- 2130.
  • 8Gutierrez- Rodriguez O, Starusta- Baeal, P and Gutierrez- Montes, O. Starusta-Bacal and O. Gutierrez-Montes, Treatment of refractory rheumatoid arthritis:the thalidomide experience[J]. JRheumatol, 1989, 16(2); 158-163.
  • 9Lehman TJ, Striegel KH, Onel KB. Striegel and K.B. Onel, Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis[J].J Pediatr, 2002, 140(1): 125-127.
  • 10vedathamuryudan MD, Cemmat MD, Sebahattinsaip MD, et al. Thalidomide in the treatment of the mucocutaneous lesions of the behcet syndrome:a randomized, double- blind, placebo-controlled trial[J]. Ann Intern Med, 1998,128(6):443-450.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部